Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults
Part of paid clinical trials in Missoula, Montana.
- Sponsor
- University of Montana
- Study ID
- NCT07539987
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Blood Pressure
- Cardiovascular Diseases
- Cholesterol
- Cholesterol, HDL
- Cholesterol, LDL
- Glycated Hemoglobin (HbA1c)
- Health Behavior
- Indoor Air Quality
- Particulate Matter
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 79 Years
- Healthy Volunteers
- Not accepted
Interventions
- Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE) — BEHAVIORALThe AIRWISE intervention consists of a 3-pronged approach grounded in the Health Belief Model (HBM) to improve residential indoor air quality through education, equipment, and behavioral cues. To reinforce cues to action, AIRWISE uses alerts from air quality sensors, prompting timely behavioral responses. Specifically, indoor and outdoor air quality alerts act as behavioral cues to promote active engagement and reference a decision matrix with specific recommendations based indoor and outdoor air quality. Recommendations on the decision matrix include simple strategies to reduce air pollution exposures, including increasing use and fan speed of portable air cleaners, opening or closing windows to change ventilation, and changing activities such as physical activity, cooking, and cleaning. This integrated approach promotes sustained behavior change by aligning with all key HBM constructs.
- Portable Air Cleaner (PAC) Control — OTHERParticipants will use two PACs in their home according to manufacturer recommendations. PAC Control group participants will not receive further education on air quality or recommendations on PAC use, nor will they receive additional equipment or outdoor AQI alerts. Control participants will use and maintain the PACs at their own discretion.
Study Details
Particulate matter air pollution is the leading environmental risk factor of cardiovascular disease and is increasing in the Western United States due to more frequent and severe wildfires. Older adults are particularly susceptible to both air pollution exposures and the development of cardiovascular disease, and the older adult population in the United States is rapidly growing. Given the converging threats of worsening air quality and an aging population, this clinical trial will evaluate a novel, multifaceted indoor air quality intervention to improve cardiovascular health outcomes among older adults in the wildfire-impacted state of Montana.
Key Dates
- Start date
- Aug 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2030
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 154 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: AIRWISE InterventionParticipants randomized to the AIRWISE Intervention group will use AIRWISE in their homes for 12 months. The AIRWISE group will use two PACs to filter indoor air and two optical PM2.5 sensors with lights that change color in real time according to AQI. In addition, automated outdoor air quality alerts are sent via text and email when outdoor AQI goes above 75 (mid-point of the Moderate AQI category). Outdoor air quality will be referenced from the Environmental Protection Agency or PurpleAir monitor nearest to the participant's home. Based on the indoor and outdoor AQI levels, participants will reference a decision matrix and educational materials to make informed decisions on improving indoor air quality. Education and behavioral strategies are delivered through multiple approaches, including visual aids, handouts, videos, and a magnet with the decision matrix that can be placed in an accessible location in the home.
- Active Comparator: PAC ControlParticipants randomized to the PAC Control group will use two PACs in their home without additional AIRWISE equipment/education. After randomization, they will be given instructions on study procedures and using the PAC units according to manufacturer recommendations. PAC Control group participants will not receive further education on air quality or recommendations on PAC use, nor will they receive additional equipment or outdoor AQI alerts. They will receive PurpleAir sensors without an AQI light that are for data collection purposes only, and they will not have access to the data throughout the study. Control participants will use and maintain the PACs at their own discretion. At the end of their participation, they will have the option of receiving the additional AIRWISE components.
Primary Outcome Measure
Predicting Risk of CVD EVENTs (PREVENT) Score [ Time Frame: 0, 6, 12 months ]
Central Contacts
- Ethan S Walker, PhD406-243-2063
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Montana | Missoula | Montana | 59812 |
Find similar trials in Missoula, MT
Related Studies
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePHASE3 · Recruiting · Boehringer Ingelheim · Anniston, Alabama
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Cardiovascular BiorepositoryEnrolling By Invitation · Kenneth S. Campbell · Lexington, Kentucky
- TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)Recruiting · Brigham and Women's Hospital · Boston, Massachusetts